Osteoporosis

Primary Care - Clinics in Office Practice

Volumn 33, Issue 4, 2006, Pages 943-951

  Rizer, Milisa K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; COLECALCIFEROL; ETIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; PREDNISONE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; VITAMIN D;

AGING; BONE FRAGILITY; CALCIUM DEFICIENCY; COST OF ILLNESS; DISABILITY; DRUG DOSE INCREASE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FRAGILITY FRACTURE; GENETICS; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; LIFESTYLE; NUTRITION; OSTEOPOROSIS; PATIENT MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SCREENING TEST; SMOKING; SUPPLEMENTATION; ULTRASOUND; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY;

AGED; AGING; BONE DENSITY; CALCIUM; DIPHOSPHONATES; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; VITAMIN D;

EID: 33845296449     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2006.09.004     Document Type: Review

References (21)

1. National Osteoporosis Foundation. Fast facts about osteoporosis. Available at: www.nof.org/osteoporosis/diseasefacts.htm. Accessed January 23, 2006.
2. US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General. Available at: www.surgeongeneral.gov/library/bonehealth. Accessed January 22, 2006.
3. Riggs B.L., and Melton III L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17 5 Suppl (1995) 505S-511S
4. HSTAT. Guide to clinical preventive services. 3rd edition: recommendations and systematic evidence reviews, guide to community preventive services. Available at: www.ncbi.nlm.nih.gov. Accessed January 29, 2006.
5. Heaney R.P. Advances in therapy for osteoporosis. Clin Med Res 1 2 (2003) 93-99
6. Wallace B.A., and Cumming R.G. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 67 1 (2000) 10-18
7. Shea B., Wells G., Cranney A., et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 552-559
8. Cummings S., and Melton III L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1867
9. Dawson-Hughes B., Dallal G.E., Krall E.A., et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323 13 (1990) 878-883
10. Papadimitropoulos E., Wells G., Shea B., et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23 4 (2002) 560-569
11. Chapuy M.C., Arlot M.E., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327 23 (1992) 1637-1642
12. The US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Available at: www.ahrq.gov/clinic/3rdduspstf/osteoporosis/osteorr.htm. Accessed December 27, 2005.
13. Nelson H., Helfand M., Woolf S., et al. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 137 (2002) 529-541
14. Cronholm P. Densitometry identifies women in whom treatment will reduce fracture risk. J Fam Pract 52 2 (2003)
15. Brown J., and Josse R. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 Suppl 10 (2002) S1-S34
16. South-Paul J.E. Osteoporosis: Part 1. Evaluation and assessment. Am Fam Physician 63 (2001) 897-904 908
17. Neff M. Practice guidelines: ACOG releases guidelines for clinical management of osteoporosis. Available at: www.aafp.org/afp/20040315/practice.html. Accesed February 5, 2006.
18. Cranney A., Guyatt G., Griffith L., et al. Meta-analysis of osteoporosis therapies for postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 570-578
19. Allen M.L., and Watt L. Guidelines for the diagnosis, screening and treatment of osteoporosis in women. Adv Stud Med 5 10 (2005) 518-523
20. National Osteoporosis Foundation. Pharmacologic options for drug treatment of osteoporosis. Accessed at www.nof.org/physguide/pharmacologic.htm on 1/29/2006.
21. Rosen C.J., Hochberg M.C., Bonnick S.L., et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res 20 1 (2005) 141-151